Analyst Research Report Snapshot


Aurobindo Pharma Limited






07 Jul 2015





Companies referenced:

Available for Immediate Download

Aurobindo Pharma Limited (APL) develops, manufactures and markets active pharmaceutical ingredients (APIs) and finished dosage formulations. The company develops product in the antibiotics, anti-retroviral, cardiovascular system (CVS), central nervous system (CNS), gastroenterological, anti-diabetics and anti-allergic areas. APL operates in Asia Pacific, Europe, South Africa, Australia and the Americas. It is headquartered in Hyderabad, India and employs around 9,500 people. The company recorded revenues of INR80,997.9 million (approximately $1,347.8 million) in the fiscal year ended March 2014, an increase of 38.3% over 2013. The company's operating profit was INR18,426.8 million (approximately $306.6 million) in fiscal 2014, as compared to an operating profit of INR6,407.5 million (approximately $106.6 million) in 2013. Its net profit was INR11,728.5 million (approximately $195.2 million) in fiscal 2014, as compared to the net profit of INR2,938.6 million (approximately $48.9 million) in 2013.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.